Literature DB >> 17570940

Cell cycle regulatory proteins in podocyte health and disease.

Caroline B Marshall1, Stuart J Shankland.   

Abstract

The glomerular visceral epithelial cell, or podocyte, is a highly specialized and terminally differentiated cell that is fundamental to the integrity of the glomerular filtration barrier and functions to prevent urinary protein leakage and to oppose intracapillary hydrostatic pressure. Common to many human kidney diseases and experimental animal models is a strong association between podocyte injury and the development of progressive kidney disease. Studies have shown that a decline in podocyte number strongly correlates with, and likely underlies, proteinuria and the progression to glomerulosclerosis. Maintenance of podocyte differentiation, essential to its normal structure and function, is challenged in the setting of glomerular injury, with very divergent outcomes dependent upon the inciting injury. In response to injury, podocytes may undergo several cell fates, including proliferation, de-differentiation, hypertrophy, apoptosis, or necrosis. Common to these potential outcomes of renal injury is their ultimate regulation at the level of the cell cycle. Positive regulators (cyclins and cyclin-dependent kinases) and negative regulators (cyclin-dependent kinase inhibitors) coordinate the cell cycle. There is now a large body of literature confirming the importance of cell cycle regulatory proteins in the cellular response to injury. Emerging lessons from mouse knockout experiments highlight that the cell cycle machinery operates differently in distinct cell types. Recent studies focusing on the roles of cell cycle regulatory proteins specifically in podocytes have provided important clues on how these proteins operate to constrain cell proliferation and preserve differentiation in health, and how they modulate the dysregulated phenotype in diseased states. In disease, both a failure to regenerate lost podocytes and an inappropriate proliferative response can have profound consequences for glomerular structure and function. Here, we will review the latest advances in understanding the roles of cell cycle regulatory proteins in diseases of the podocyte. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17570940     DOI: 10.1159/000101793

Source DB:  PubMed          Journal:  Nephron Exp Nephrol        ISSN: 1660-2129


  26 in total

1.  Podocyte Number in Children and Adults: Associations with Glomerular Size and Numbers of Other Glomerular Resident Cells.

Authors:  Victor G Puelles; Rebecca N Douglas-Denton; Luise A Cullen-McEwen; Jinhua Li; Michael D Hughson; Wendy E Hoy; Peter G Kerr; John F Bertram
Journal:  J Am Soc Nephrol       Date:  2015-01-07       Impact factor: 10.121

Review 2.  A potential role for mechanical forces in the detachment of podocytes and the progression of CKD.

Authors:  Wilhelm Kriz; Kevin V Lemley
Journal:  J Am Soc Nephrol       Date:  2014-07-24       Impact factor: 10.121

Review 3.  Rethinking glomerular basement membrane thickening in diabetic nephropathy: adaptive or pathogenic?

Authors:  Caroline B Marshall
Journal:  Am J Physiol Renal Physiol       Date:  2016-08-31

4.  Cell cycle re-entry sensitizes podocytes to injury induced death.

Authors:  Manuel Hagen; Eva Pfister; Andrea Kosel; Stuart Shankland; Jeffrey Pippin; Kerstin Amann; Christoph Daniel
Journal:  Cell Cycle       Date:  2016-05-27       Impact factor: 4.534

5.  Ouabain activates the Na-K-ATPase signalosome to induce autosomal dominant polycystic kidney disease cell proliferation.

Authors:  Anh-Nguyet T Nguyen; Kyle Jansson; Gladis Sánchez; Madhulika Sharma; Gail A Reif; Darren P Wallace; Gustavo Blanco
Journal:  Am J Physiol Renal Physiol       Date:  2011-06-22

Review 6.  Shiga toxin triggers endothelial and podocyte injury: the role of complement activation.

Authors:  Carlamaria Zoja; Simona Buelli; Marina Morigi
Journal:  Pediatr Nephrol       Date:  2017-12-06       Impact factor: 3.714

7.  Systematic analysis of a novel human renal glomerulus-enriched gene expression dataset.

Authors:  Maja T Lindenmeyer; Felix Eichinger; Kontheari Sen; Hans-Joachim Anders; Ilka Edenhofer; Deborah Mattinzoli; Matthias Kretzler; Maria P Rastaldi; Clemens D Cohen
Journal:  PLoS One       Date:  2010-07-12       Impact factor: 3.240

8.  Histological study on effect of mesenchymal stem cell therapy on experimental renal injury induced by ischemia/reperfusion in male albino rat.

Authors:  Eman Mostafa Sadek; Noha Mohamed Afifi; Lamiaa Ibrahim Abd Elfattah; Manal Ali Abd-El Mohsen
Journal:  Int J Stem Cells       Date:  2013-05       Impact factor: 2.500

9.  Mycophenolate mofetil inhibits hypertrophy and apoptosis of podocyte in vivo and in vitro.

Authors:  Wei Lv; Jingqiu Lou; Yan Zhang; Peiwen Lian; Dong Qi; Jianping Wang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

10.  The association of cell cycle checkpoint 2 variants and kidney function: findings of the Family Blood Pressure Program and the Atherosclerosis Risk In Communities study.

Authors:  Nora Franceschini; Kari E North; Donna Arnett; James S Pankow; Jay H Chung; Lisa Baird; Mark F Leppert; John H Eckfeldt; Eric Boerwinkle; C Charles Gu; Cora E Lewis; Richard H Myers; Stephen T Turner; Alan Weder; W H Linda Kao; Thomas H Mosley; Aravinda Chakravarti; Holly Kramer; Jinghui Zhang; Steven C Hunt
Journal:  Am J Hypertens       Date:  2009-03-05       Impact factor: 2.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.